RecruitingNCT06305208

A UK Registry for Metabolic and Bariatric Endoscopic Interventions


Sponsor

Cleveland Clinic London

Enrollment

300 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

In the UK alone, obesity is a major health problem with more than one quarter of adults estimated to be obese. Obesity promotes the development of many serious diseases including diabetes, heart disease, kidney disease, and increased risk of some cancers. Patients living with obesity also suffer from significant symptoms that impact their life including shortness of breath, back pain, poor mobility, and poor mental health. Traditional methods to help lose weight include low calorie diets and increased exercise. These may be effective in the short-term, but due to powerful biological mechanisms they are hard to maintain over the long-term and most individuals are unable to achieve normal weight. This means many people may need bariatric surgery that is highly effective at lowering body weight, but it is associated with complications and not all patients will want or be able to undergo surgery. This has led to the development of many new obesity treatments that are completed with an endoscope. An endoscope is a thin flexible tube that has a camera at the end. It is inserted through the mouth and into the stomach and small bowel. There are various procedures that can be done at the time of endoscopy that have been shown to be effective with a low number of side-effects. These are still relatively new compared to more traditional treatments and only a small number of doctors can perform them within the UK. Due to these limitations, the aim of this registry is to obtain real-world information on the safety and effectiveness of these procedures across the UK. The investigators hope over time this will improve the knowledge of clinicians about treating obesity with endoscopy and support future access and funding to these treatments.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria3

  • Any patient undergoing a primary or revisional bariatric or metabolic endoscopic procedure.
  • Age ≥ 18 years old
  • Able to give written informed consent.

Exclusion Criteria3

  • Any bariatric or metabolic endoscopic procedure performed outside the UK.
  • Any bariatric or metabolic endoscopic procedure not currently listed within the registry protocol or agreed by the steering committee.
  • Unable to provide written informed consent.

Interventions

DEVICEEndoscopic gastric suturing

Endoscopic suturing of the stomach to reduce volume and promote weight loss with either the Apollo Overstitch or Overstitch Sx system.

DEVICEEndoscopic gastric plication

Endoscopic plication of the stomach to reduce volume and promote weight loss with either the POSE or Endomina system.

DEVICERevisional gastroplasty

Endoscopic suturing or plication of the stomach among patients who have previously undergone gastroplasty, sleeve gastrectomy, or Roux-en-Y gastric bypass to restrict the stomach and promote weight loss

DEVICETransoral outlet reduction endoscopy (TORe)

Reduction of the size of the gastro-jejunal anastomosis among patients who have previously undergone Roux-en-Y gastric bypass to promote weight loss. A variety of techniques may be used alone or in isolation including suturing (Apollo Overstitch), plication (POSE), argon photocoagulation, and endoscopic submucosal resection/dissection.

DEVICEDuodenal mucosal resurfacing (DMR)

Endoscopic ablation of the post-ampullary duodenal mucosal to enhance improvement in glycaemic control among patients with type 2 diabetes.

DEVICEIntragastric balloon(s)

The insertion of an intragastric implant into the stomach, which is subsequently filled with air or water to promote weight loss. Several intragastric balloons are available including Allurion, Heliosphere, Obalon, Orbera, and Spatz.


Locations(1)

Cleveland Clinic London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06305208


Related Trials